IJMS | Free Full-Text | Exploiting RAS Nucleotide Cycling as a Strategy for Drugging RAS-Driven Cancers | HTML
About the RAS Initiative - National Cancer Institute
Frontiers | Divergent Mechanisms Activating RAS and Small GTPases Through Post-translational Modification | Molecular Biosciences
IJMS | Free Full-Text | Exploiting RAS Nucleotide Cycling as a Strategy for Drugging RAS-Driven Cancers | HTML
Drugging the undruggable RAS: Mission Possible? | Nature Reviews Drug Discovery
A Sos proteomimetic as a pan-Ras inhibitor | PNAS
Oncogenic G12D mutation alters local conformations and dynamics of K-Ras | Scientific Reports
Isoform-specific ras functions in development and cancer | Future Oncology
A Sos proteomimetic as a pan-Ras inhibitor | PNAS
![PDF] Dragging ras back in the ring. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/762e381c6e7d12b2f0aeb4bb4ab82b96b1a8fa82/3-Table2-1.png "PDF] Dragging ras back in the ring. | Semantic Scholar")
PDF] Dragging ras back in the ring. | Semantic Scholar
![PDF] Dragging ras back in the ring. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/762e381c6e7d12b2f0aeb4bb4ab82b96b1a8fa82/5-Figure3-1.png "PDF] Dragging ras back in the ring. | Semantic Scholar")
PDF] Dragging ras back in the ring. | Semantic Scholar
Inhibition of Nonfunctional Ras - ScienceDirect
Dragging Ras Back in the Ring - ScienceDirect
Oncogenic RAS isoforms show a hierarchical requirement for the guanine nucleotide exchange factor SOS2 to mediate cell transformation
Full article: Approaches to inhibiting oncogenic K-Ras
K-Ras: Oncogenic protein and anti-cancer drug target
Full article: RAS oncogenes direct metastasis
Targeting RAS Membrane Association: Back to the Future for Anti-RAS Drug Discovery? | Clinical Cancer Research
Targeting RAS Membrane Association: Back to the Future for Anti-RAS Drug Discovery? | Clinical Cancer Research
Dragging Ras Back in the Ring - ScienceDirect
IJMS | Free Full-Text | Exploiting RAS Nucleotide Cycling as a Strategy for Drugging RAS-Driven Cancers | HTML
Identification of RAS mutant biomarkers for EGFR inhibitor sensitivity using a systems biochemical approach - ScienceDirect
Blockade of mutant RAS oncogenic signaling with a special emphasis on KRAS - ScienceDirect
The discovery and maturation of peptide biologics targeting the small G-protein Cdc42: A bioblockade for Ras-driven signaling - Journal of Biological Chemistry
RAS diseases in children | Haematologica
